Detailed answers about EMERALD HEXAGON BIOPHARMA LIMITED, including incorporation, status, business activity, and accounts information.
When was EMERALD HEXAGON BIOPHARMA LIMITED founded?
EMERALD HEXAGON BIOPHARMA LIMITED was officially incorporated on 21 February 2023 and is registered under company number 14680589. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is EMERALD HEXAGON BIOPHARMA LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of EMERALD HEXAGON BIOPHARMA LIMITED?
EMERALD HEXAGON BIOPHARMA LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does EMERALD HEXAGON BIOPHARMA LIMITED do?
EMERALD HEXAGON BIOPHARMA LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is EMERALD HEXAGON BIOPHARMA LIMITED's registered address?
The registered office address of EMERALD HEXAGON BIOPHARMA LIMITED is 5 BRIDGE STREET, WALTON ON THAMES, SURREY, ENGLAND, KT12 1AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is EMERALD HEXAGON BIOPHARMA LIMITED financially stable?
The most recent accounts for EMERALD HEXAGON BIOPHARMA LIMITED were made up to 28 February 2025, filed as DORMANT. Next accounts are due by 30 November 2026.
Has EMERALD HEXAGON BIOPHARMA LIMITED changed its name?
Yes, EMERALD HEXAGON BIOPHARMA LIMITED has had 1 previous name: CELLAAX BIOPHARMA LIMITED (changed 26 February 2026).